Clinical Trials at Oregon Health & Science University
As of June 2026, 175 paid clinical trials are recruiting at Oregon Health & Science University, located at 3181 SW SAM JACKSON PARK RD, MAIL CODE UHN-88, ATTN. LIZ STEVENSON, PORTLAND, OR 97239-3011, phone (503) 494-8744 in Portland, Oregon. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Endometrial Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
175 clinical trials at Oregon Health & Science University
·Clear filters·↓ Download CSVPrecision T1D Platform - New Therapies for Cardio-Renal Complications
A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Valproic AcId for Traumatic BRAin INjury Trial
Sodium and Milk Fortification Evaluation of Body Composition Among Very Preterm Infants
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Cefotetan Therapy for Escherichia Coli Infections
Epetraborole in Patients With Mycobacterium Abscessus Lung Disease
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness
Insights in Endocervical Mucus Secretion
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy
Opt-In Early Pilot Study
Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management
Hyperangulated Versus Standard Geometry Laryngoscope Blade Trial
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
Clinical Course Of Disease In Participants With FA-CM
Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
At Home Ammonia Monitoring of Inborn Errors of Ammonia Metabolism
Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
Injection Versus Suture Repair of Laryngeal Clefts
Physical Therapy After Endometriosis Excision
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
About research studies in Portland
Portland has approximately 1,082 recruiting research studies across a wide range of therapeutic areas. Oregon hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Common conditions studied in Portland
- Acute Myeloid Leukemia (20 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (20 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Endometrial Cancer (19 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Heart Failure (17 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Ovarian Cancer (15 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
- Advanced Solid Tumor (14 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Portland
- Oregon Health and Science University
- National Cancer Institute (NCI)
- OHSU Knight Cancer Institute
- AstraZeneca
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in Oregon are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Oregon research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Portland. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Portland
Hipa.ai aggregates every recruiting study in Portland from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Portland?
There are approximately 1,082 recruiting clinical trials in Portland, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Portland pay participants?
Most recruiting trials in Portland compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Portland?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Portland?
The most common conditions under active study in Portland include Acute Myeloid Leukemia (20), Breast Cancer (20), Endometrial Cancer (19), Heart Failure (17), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Portland?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Portland on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Portland?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Portland?
Recruiting research sites in Portland include Oregon Health and Science University, Oregon Health & Science University, Providence Portland Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Portland right now?
The largest active categories in Portland are Cancer & tumors (391), Neurology & pain (67), Cardiovascular (47). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Oregon Health & Science University?
Oregon Health & Science University is located at 3181 SW SAM JACKSON PARK RD, MAIL CODE UHN-88, ATTN. LIZ STEVENSON, PORTLAND, OR 97239-3011. Use the Google Maps link in the intro above to get directions.
How do I contact Oregon Health & Science University?
You can reach Oregon Health & Science University by phone at (503) 494-8744. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.